“Tirbanibulin Ointment 1%, a Novel Inhibitor of Tubulin Polymerization and Src Kinase Signaling , for the Treatment of Actinic Keratosis (AK): Results from Two Pivotal Phase III Studies” (2020) SKIN The Journal of Cutaneous Medicine, 4(5), p. s63. doi:10.25251/skin.4.supp.62.